Peng Liang
Founder, Chief Scientific Officer & Chairman of the BoardDr. Peng Liang, Ph.D. is Co-Founder, President and Chairman at Sichuan Clover Biopharmaceuticals, Inc. Dr. Liang is Founder and CEO of GenHunter Corporation. He serves as Chairman of the Board at Clover Biopharmaceuticals, Ltd. and serves as its Director and Chief Scientific Officer since October 31, 2018. He is Founder of Clover Biopharmaceuticals, Ltd. He is Inventor of Trimer-Tag© technology. He is Co-inventor of Differential Display technology. He discovered IL-24 and its receptors (licensed to Wyeth). He is Winner of 1998 Molecular Bioanalytics Prize from the German Society of Biological Chemistry and Molecular Biology. He has Published 75+ original research papers in peer-reviewed journals. He was Associate Professor of Cancer Biology, Vanderbilt University. He was Postdoc from Harvard Medical School. He holds PhD in Biochemistry from University of Illinois and BS in Biology from Beijing University.
Positions
- Company NameClover Biopharmaceuticals, Ltd.Stock Code02197PositionFounder, Chief Scientific Officer & Chairman of the BoardColleagues
- JGJoshua G. LiangCEO & Executive Director
- YLYang LiChief Technology Officer
- HHHtay Htay HanChief Medical Officer of Vaccine
- BMBerry MichaelChief Technical Operation Officer
- XWXiaobin WuIndependent Non-Executive Director
- TEThomas Edward LeggettIndependent Non-Executive Director
- XWXiaodong WangNon-Executive Director
